United States Artificial Kidney Market

United States Artificial Kidney Market Size & Forecast:

• United States Artificial Kidney Market Size 2025: USD 185.92 Million
• United States Artificial Kidney Market Size 2033: USD 307.08 Million 
• United States Artificial Kidney Market CAGR: 6.50%
• United States Artificial Kidney Market Segments:By Type (Wearable Artificial Kidney, Implantable Artificial Kidney), By End User (Hospitals, Dialysis Centers, Research Institutes).

To learn more about this report,  Download Free Sample Report

United States Artificial Kidney Market Summary: 

The United States artificial kidney market size is estimated at USD 185.92 million in 2025 and is anticipated to reach USD 307.08 million by 2033, growing at a CAGR of 6.50% from 2026 to 2033. The United States artificial kidney market shows strong growth because patients need better solutions to treat chronic kidney disease. The ageing population, together with rising kidney failure cases, drives research for new wearable and implantable medical devices. Companies are developing solutions that enhance patient comfort while improving their ability to move and achieve better health results. Government-backed programmes together with current medical studies create additional momentum for market expansion. The market demonstrates a positive transformation because it provides efficient medical solutions that improve patient health results beyond standard dialysis methods.

Key Market Trends & Insights: 

• Patients are looking for dialysis options that provide them with easier access. The development of wearable and portable artificial kidneys currently provides users with enhanced mobility advantages while delivering better life quality.

• The rising number of kidney disease cases among older people creates a demand for medical services. The market expansion depends on two factors, which are early diagnosis and treatment implementation.

• U.S. federal programs together with healthcare policies create an environment that supports both research activities and the development of renal care technologies. The progress of product development, together with clinical trials, receives support through funding and grant programmes.

• Manufacturers create medical devices that match the specific requirements of each patient, which results in better treatment results. This method focuses on delivering comfortable solutions which decrease hospital admissions while improving patients' capacity to manage their health.

• The main companies in the industry work together with academic institutions and medical facilities to expedite the process of creating new products. The partnerships enable organisations to conduct product testing while obtaining regulatory permissions and building their distribution systems.

United States Artificial Kidney Market Segmentation

By Type

• Wearable Artificial Kidney: The development of wearable artificial kidneys enables patients to move freely while maintaining their independence from medical facilities. The devices provide patients with permanent dialysis treatment, which enables them to lead better lives. The U.S. artificial kidney market experiences growth because people now prefer wearable solutions that become more comfortable through technological progress and higher product knowledge among users.

• Implantable Artificial Kidney: The development of implantable artificial kidneys creates a new path for kidney treatment because these devices replace natural kidney operations through their internal functioning. The treatment helps patients achieve better results because it decreases their need for dialysis sessions. The research and clinical trials are advancing, piloting biocompatibility studies and safety assessments which establish implantable devices as a developing market segment in the United States.

To learn more about this report,  Download Free Sample Report

By End User

• Hospitals: The main users of hospital services provide advanced kidney failure treatments to their patients. Hospitals are adopting artificial kidneys because they enable better patient tracking through their combination of trained personnel and healthcare system connections. Hospitals conduct clinical studies which help test new technologies in their research work.

• Dialysis Centers: Dialysis centres are expanding their offerings with wearable and semi-portable devices. The organisation delivers continuous medical assistance to individuals with chronic kidney disease while they work to implement upcoming medical advancements. Dialysis centres operate as essential pathways for artificial kidney distribution because they deliver services that prioritise patient needs through effective operational methods.

• Research Institutes: Research institutes develop artificial kidney technologies by researching new biomaterials and filtration systems and implantable designs. The research institutes establish themselves as essential market drivers by partnering with industry organisations and receiving government funding to enhance their clinical trial capabilities and product development processes.

Country Insights

The artificial kidney market in the United States exists as the leading market because of technological innovations and increasing healthcare investments and the growing number of patients who suffer from chronic kidney disease. The demand for advanced renal care solutions increases because of the dual factors of population growth among elderly people and the rising incidence of diabetes and hypertension. 

The hospital and specialised dialysis centre sectors are experiencing rapid adoption of wearable and implantable artificial kidneys, which provide patients with enhanced mobility and better living standards. The combination of government projects and research funding along with public-private partnerships is creating a faster pace for product advancement and clinical research activities. The combination of awareness campaigns and early diagnosis programmes enables greater patient access to advanced medical treatments. 

The U.S. market benefits from a robust system that includes research institutes and medical device manufacturers which drive innovation and accelerate the introduction of new technologies. The country serves as a vital centre that drives the worldwide development and progress of artificial kidney technologies.

Recent Development News

US Startups Earn FDA ‘Breakthrough Device’ Status for Kidney Tech: Innovative U.S. startups have secured the FDA Breakthrough Device designation for continuous artificial kidney technology, signalling strong potential to reshape dialysis care and improve patient freedom from stationary machines.

Renal Disease Treatment Devices Market Forecast Grows Toward 2035: A recent report finds that rising demand for renal care devices, driven by aging demographics and chronic kidney disease, is bolstering market prospects for artificial kidney technologies in the U.S. healthcare landscape. 

Key United States Artificial Kidney Company Insights

Leading companies in the U.S. artificial kidney market are focusing on two main aspects. The first aspect involves developing new technologies. The second aspect requires developing solutions which meet the needs of patients. The key players of the market are developing two types of technologies. These technologies include wearable devices and implantable devices. The technologies provide users with improved operational performance. The technologies also ensure user safety. The technologies provide users with better comfort. Product development and clinical adoption processes receive support through research institute partnerships and healthcare provider collaborations. Companies are developing regulatory compliance systems together with personalised treatment methods to enhance their market reach. The organisations develop new renal care methods through continuous technology development and their dedication to patient requirements.

Company List

• Medtronic PLC
• Fresenius Medical Care AG & Co. KGaA
• Baxter International Inc.
• B. Braun Melsungen AG
• Asahi Kasei Corporation
• Nipro Corporation
• Quanta Dialysis Technologies Ltd.
• AWAK Technologies Pte Ltd.
• Outset Medical Inc.
• Diality Inc.
• NxStage Medical Inc.
• Cantel Medical Corporation
• DaVita Inc.
• Renal Solutions Inc.
• Toray Medical Co. Ltd.

United States Artificial Kidney Market Report Segmentation

By Type

• Wearable Artificial Kidney
• Implantable Artificial Kidney

By End User

• Hospitals
• Dialysis Centers
• Research Institutes